 |
| News Alert: BICX CFO Reviews 2013 Annual Report for Shareholders |
|
 Hot Stock to Watch |
Company: BioCorRx Inc. (OTCQB: BICX)
|
Last:
Price: 0.15
Change (%): - 0.02 (11.76)
Volume: 251,802 |
 |
BioCorRx, Inc. CFO, Lourdes Felix discusses 10-K Filing for 2013
Los Angeles, April 15, 2014 (GLOBE NEWSWIRE) - BioCorRx, Inc. (BICX), a leader in addiction treatment programs, announces its financial results for the 12 months ending December 31, 2013. The full 10-K filing is available on the SEC’s website at http://edgar.sec.gov/
An audio interview with Lourdes Felix, CFO and Brady Granier, COO is available by clicking here. The audio clip gives investors an overview of the 2013 results as well as expectations for 2014.
Due to the unpredictable nature of insurance billing and reimbursements, the earnings reported vary from what was projected earlier in the year. “We did have substantial discounts that we had to book at the end of the year, but overall we were quite happy with the revenues generated in 2013”, stated CFO Lourdes Felix. The Company was able to sign several licensing deals in 2013 that generated significant cash flow for the year. These licensing deals also show a promising potential for growth in 2014. “Because of the cash flow influx last year we were able to pretty much sustain ourselves and pay our monthly obligations, so that made us feel very good about the direction the company was going in. We did not have to go out and borrow any funds or get into any type of heavy contracts [in 2013]”, says Felix.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
